ArticleFrontiers in immunology2017

Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas.

Massimo Fantini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.